ZA884262B - Pharmaceutical composition for the treatment of tumors - Google Patents
Pharmaceutical composition for the treatment of tumorsInfo
- Publication number
- ZA884262B ZA884262B ZA884262A ZA884262A ZA884262B ZA 884262 B ZA884262 B ZA 884262B ZA 884262 A ZA884262 A ZA 884262A ZA 884262 A ZA884262 A ZA 884262A ZA 884262 B ZA884262 B ZA 884262B
- Authority
- ZA
- South Africa
- Prior art keywords
- tumors
- treatment
- pharmaceutical composition
- dipyridamole
- interferon
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 102000014150 Interferons Human genes 0.000 abstract 1
- 108010050904 Interferons Proteins 0.000 abstract 1
- 230000000259 anti-tumor effect Effects 0.000 abstract 1
- IZEKFCXSFNUWAM-UHFFFAOYSA-N dipyridamole Chemical compound C=12N=C(N(CCO)CCO)N=C(N3CCCCC3)C2=NC(N(CCO)CCO)=NC=1N1CCCCC1 IZEKFCXSFNUWAM-UHFFFAOYSA-N 0.000 abstract 1
- 229960002768 dipyridamole Drugs 0.000 abstract 1
- 229940079322 interferon Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP87108708A EP0295317A1 (en) | 1987-06-16 | 1987-06-16 | Pharmaceutical composition for the treatment of tumors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA884262B true ZA884262B (en) | 1990-02-28 |
Family
ID=8197069
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA884262A ZA884262B (en) | 1987-06-16 | 1988-06-15 | Pharmaceutical composition for the treatment of tumors |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US4997645A (enExample) |
| EP (2) | EP0295317A1 (enExample) |
| JP (1) | JPS63316722A (enExample) |
| KR (1) | KR890000108A (enExample) |
| AT (1) | ATE59780T1 (enExample) |
| AU (1) | AU622404B2 (enExample) |
| DE (1) | DE3861494D1 (enExample) |
| DK (1) | DK328088A (enExample) |
| HU (1) | HU200942B (enExample) |
| PH (1) | PH27069A (enExample) |
| ZA (1) | ZA884262B (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5215744A (en) * | 1987-06-16 | 1993-06-01 | Boehringer Ingelheim Gmbh | Methods for the treatment of tumors |
| GB8813032D0 (en) * | 1988-06-02 | 1988-07-06 | Boehringer Ingelheim Int | Antiviral pharmaceutical composition |
| US6003516A (en) * | 1992-06-03 | 1999-12-21 | Maxim Pharmaceuticals, Inc. | Method for treatment of cancer and infectious disease |
| SE513429C2 (sv) * | 1992-06-03 | 2000-09-11 | Syntello Inc | Preparat för aktivering av naturliga mördarceller, vilket preparat innehåller interferon alfa och biogena aminer |
| US5480640A (en) * | 1995-05-02 | 1996-01-02 | Schering Corporation | Alpha interferon for treating prostate cancer |
| US6155266A (en) * | 1995-05-08 | 2000-12-05 | Maxim Pharmaceuticals, Inc. | Method for treatment of cancer and infectious disease |
| US20020099003A1 (en) | 1997-10-28 | 2002-07-25 | Wilson Leland F. | Treatment of female sexual dysfunction with vasoactive agents, particularly vasoactive intestinal polypeptide and agonists thereof |
| US7064130B2 (en) * | 2001-04-20 | 2006-06-20 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Use of radical-scavenging compounds for treatment and prevention of NO-dependent microcirculation disorders |
| JP7641894B2 (ja) * | 2018-09-27 | 2025-03-07 | アイテオ ベルギウム エスエー | がん治療におけるｅｎｔファミリートランスポーター阻害剤の使用及びそのアデノシン受容体アンタゴニストとの組み合わせ |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3031450A (en) * | 1959-04-30 | 1962-04-24 | Thomae Gmbh Dr K | Substituted pyrimido-[5, 4-d]-pyrimidines |
| BG36086A1 (en) * | 1982-01-19 | 1984-09-14 | Glbov | Method for inducing interferon |
-
1987
- 1987-06-16 EP EP87108708A patent/EP0295317A1/en not_active Withdrawn
-
1988
- 1988-04-06 JP JP63084985A patent/JPS63316722A/ja active Granted
- 1988-06-08 AT AT88109121T patent/ATE59780T1/de active
- 1988-06-08 EP EP88109121A patent/EP0295559B1/en not_active Expired - Lifetime
- 1988-06-08 DE DE8888109121T patent/DE3861494D1/de not_active Expired - Fee Related
- 1988-06-14 KR KR1019880007101A patent/KR890000108A/ko not_active Ceased
- 1988-06-15 ZA ZA884262A patent/ZA884262B/xx unknown
- 1988-06-15 HU HU883081A patent/HU200942B/hu not_active IP Right Cessation
- 1988-06-15 AU AU17681/88A patent/AU622404B2/en not_active Ceased
- 1988-06-15 DK DK328088A patent/DK328088A/da unknown
- 1988-06-16 US US07/207,622 patent/US4997645A/en not_active Expired - Fee Related
- 1988-06-16 PH PH37080A patent/PH27069A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU622404B2 (en) | 1992-04-09 |
| HUT47033A (en) | 1989-01-30 |
| ATE59780T1 (de) | 1991-01-15 |
| EP0295559A2 (en) | 1988-12-21 |
| EP0295559A3 (en) | 1989-03-08 |
| JPH0529365B2 (enExample) | 1993-04-30 |
| EP0295317A1 (en) | 1988-12-21 |
| DK328088D0 (da) | 1988-06-15 |
| PH27069A (en) | 1993-02-01 |
| EP0295559B1 (en) | 1991-01-09 |
| US4997645A (en) | 1991-03-05 |
| KR890000108A (ko) | 1989-03-11 |
| DK328088A (da) | 1988-12-17 |
| JPS63316722A (ja) | 1988-12-26 |
| HU200942B (en) | 1990-09-28 |
| AU1768188A (en) | 1988-12-22 |
| DE3861494D1 (de) | 1991-02-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GR3005358T3 (enExample) | ||
| ZA848369B (en) | Pharmaceutical compositions containing bilobalid for the treatment of neuropathies | |
| EP0311061A3 (en) | Composition for the surface treatment of rubber | |
| NZ227944A (en) | Synergistic pharmaceutical composition of a hybrid interferon and a muramylpeptide | |
| EP0294028A3 (en) | Fluoxetine useful for the treatment of diabetes | |
| ZA884262B (en) | Pharmaceutical composition for the treatment of tumors | |
| GR3024763T3 (en) | Use of human interferon-beta for stimulation of erythropoieses | |
| EP0204989A3 (en) | Use of penicillamine in the treatment of immune deficiency diseases | |
| ZA862630B (en) | 5-pyrimidinecarboxamides and treatment of leukemia and tumors therewith | |
| BG49522A1 (en) | Pharmaceutist composition accelarating the healing of mounds | |
| EP0378824A3 (en) | Use of omega-3-fatty acids as anticachexia agents | |
| GB2216416B (en) | Nucleobase source for the stimulation of the immune system | |
| NZ223293A (en) | Beta-alkyl melatonins and pharmaceutical compositions | |
| DE3572441D1 (en) | Use of interferon gamma (ifn-gamma) for the production of preparations for treating rheumatic diseases | |
| IL87182A0 (en) | Pharmaceutical compositions containing tumor necrosis factor for treating infections | |
| GR3018837T3 (en) | Subcutaneous administration of human chorionic gonadotrophin. | |
| GR3005231T3 (enExample) | ||
| GR3004272T3 (enExample) | ||
| JPS6452781A (en) | Novel antitumoral and antiviral composition from mrine source | |
| GR3000306T3 (en) | Composition for the treatment of infections | |
| GB8819626D0 (en) | Pharmaceutical composition for treatment of tumours | |
| DE3879709D1 (de) | Platin-arzneimittel. | |
| GB8713306D0 (en) | Materials for treatment of tumours | |
| EP0278715A3 (en) | Use of human gamma interferon for treatment of basal cell carcinoma | |
| GB8616440D0 (en) | Materials for treatment of tumours |